FDA Inspection 919494 — OsteoLife Biomedical, LLC

OsteoLife Biomedical, LLC — FEI 3007936027

The FDA completed an inspection of OsteoLife Biomedical, LLC on March 26, 2015 in Jupiter, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 26, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Jupiter, FL (United States)

Citations

IDCFRDescription
1241621 CFR 1271.260(e)Storage temperatures recorded, maintained